ephrin-B2 expression did not correlate with Gleason grade (Fig. 1a), or tumor stage (Supplementary Table 2) in this small study of resectable prostate cancers, while ephrin-B2 induction begins early in the disease. Here, EFNB2 is linked to prostate carcinoma.